| Document Date: 2011-12-23 12:58:35 Open Document File Size: 276,88 KBShare Result on Facebook
City Reference / / Company Merck / Laboratory Abnormalities / Merck Sharp & Dohme Corp. / Merck & Co. Inc. / Alteon Inc. / / Currency pence / / Event FDA Phase / / Facility Laboratory Abnormalities The / Laboratory Parameter Preferred Term / Laboratory Parameter Preferred Term LDL / Laboratory Abnormalities Reported / / IndustryTerm treatment / Monitor for Immune Reconstitution Syndrome / medicinal products / food / treatment of HIV / / MedicalCondition inflammatory response / Pneumocystis jiroveci pneumonia / headache / Myopathy / genital herpes / antierectile dysfunction / Hepatitis C / Hepatitis B / toxic epidermal necrolysis / Stevens-Johnson syndrome / conjunctivitis / severe hypersensitivity / fatigue / gastritis / residual opportunistic infections / hypersensitivity / hepatitis / phenylketonuria / organ dysfunction / illness / liver disease / Infections / nephrolithiasis / paranoia / Immune Reconstitution Syndrome / blisters / cancers / abdominal pain / insomnia / cancer / rash / constitutional findings / Nervous System Disorders / Mycobacterium tuberculosis / Carcinogenesis / chronic / joint aches / fever / rhabdomyolysis / vomiting / severe rash / varicella zoster virus / hepatic failure / angioedema / Psychiatric Disorders Insomnia / AIDS / infection / renal failure / depression / rash / psychomotor hyperactivity / eosinophilia / / MedicalTreatment antiretroviral treatment / antiretroviral therapy / / Organization Pediatrics DOSAGE AND ADMINISTRATION / FDA / / / Position investigator / General / / Product efavirenz / Chewable Tablet / Chewable Tablets / Film-Coated Tablets / omeprazole / rifampin / OR Chewable tablets / phenytoin / lamivudine / ISENTRESS / OBT ISENTRESS / ISENTRESS Efavirenz / ISENTRESS Placebo / / PublishedMedium Baseline / / Technology UDP / Pharmacokinetics / Pharmacodynamics / / URL www.fda.gov/medwatch / /
SocialTag |